J-P. Zellweger (Lausanne, Switzerland), L. Richeldi (Modena, Italy)
Gamma-interferon tests for the diagnosis of tuberculosis infection under routine conditions in Lausanne, Switzerland A. Zellweger, S. Ansermet, S. Jolivet, J. P. Zellweger (Lausanne, Switzerland)
| |
Validation of the tuberculin skin test cut off in BCG-vaccinated individuals using the QuantiFERON-TB gold test R. Piro, G. Ferrara, A. Andreani, M. Meacci, B. Meccugni, I. Marchetti, M. Losi, L. Richeldi, L. Fabbri (Modena, Italy)
| |
Latent tuberculosis infection among respiratory and clinical staff and students in Samara, Russia Y. Balabanova, I. Fedorin, V. Nikolayevskyy, S. Zakharova, N. Lebedeva, E. Zakamova, F. Drobniewski (London, United Kingdom; Samara, Russian Federation)
| |
Contribution of the T-SPOT.TB assay for differentiating active versus latent tuberculosis infection (LTBI) V. Bosshard, P. Roux-Lombard, T. Perneger, M. Metzger, R. Vivien, T. Rochat, J. P. Janssens (Geneva, Switzerland)
| |
Do results of T-SPOT.TB assays change during and after treatment of active tuberculosis? J. P. Janssens, P. Roux-Lombard, T. Perneger, M. Metzger, R. Vivien, T. Rochat (Geneva, Switzerland)
| |
Monitoring of ESAT-6/CFP-10 selected peptides response during prophylaxis in individuals exposed to M. tuberculosis D. Goletti, D. Vincenti, S. Carrara, O. Butera, F. Bizzoni, M. Amicosante, D. Dainotto, N. Petrosillo, M. P. Parracino, G. Anzidei, E. Girardi (Rome, Italy)
| |
Relationship between the whole blood interferon-gamma responses and the risk of active tuberculosis K. Higuchi, N. Harada, T. Mori (Kiyose, Japan)
| |
Contribution of the T-SPOT.TB assay for detection of latent tuberculous infection (LTBI) in contact tracing procedures J. P. Janssens, P. Roux-Lombard, T. Perneger, M. Metzger, R. Vivien, T. Rochat (Geneva, Switzerland)
| |